Analgesia and behavioral responses of dogs given oxymorphone-acepromazine and meperidine-acepromazine after methoxyflurane and halothane anesthesia.
This study was designed to test analgesia, duration, and cardiovascular changes induced by meperidine (MEP) and oxymorphone (OXY) following methoxyflurane (MOF) and halothane (HAL) anesthesia. Eight healthy dogs were given atropine and acepromazine, and anesthesia was induced with thiamylal and maintained with 1.5 minimal alveolar concentration of MOF or HAL for 1 hour during controlled ventilation. Eight treatments were given with each anesthetic: 3 with MEP (0.5, 1.0, and 2.0 mg/kg, IV), 3 with oxymorphone (OXY; 0.05, 0.1, and 0.2 mg/kg, IV), and 2 placebos with sterile water. Test drugs were given at the end of anesthesia when early signs of recovery were evident. Minimal threshold stimulus/response nociception was assessed by use of an inflatable soft plastic colonic balloon. Blood pressures and pulse rate were measured with a noninvasive monitor. Meperidine and OXY were found to be effective analgesics and could be reversed with naloxone. Intravenous administration of 2.0 mg of MEP/kg provided analgesia for 36 +/- 6 minutes and 39 +/- 15 minutes after MOF and HAL, respectively. In contrast, OXY was effective at all 3 doses with effects of IV administration of 0.2 mg of OXY/kg lasting 154 +/- 13 minutes and 152 +/- 12 minutes, after MOF and HAL, respectively. Analgesia could not be demonstrated after anesthesia for acepromazine, MOF, or HAL. Blood pressure was not changed by either anesthetic nor was it influenced by MEP or OXY. Pulse rate was significantly depressed by the higher doses of OXY following HAL, but was not changed by MEP following either anesthetic.(ABSTRACT TRUNCATED AT 250 WORDS)
Sawyer
D C
DC
Department of Small Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lansing 48824-1316.
Rech
R H
RH
Adams
T
T
Durham
R A
RA
Richter
M A
MA
Striler
E L
EL
D000075:Acepromazine / Q000494:pharmacology*; D000698:Analgesia / Q000662:veterinary*; D000758:Anesthesia / Q000662:veterinary; D000818:Animals; D004285:Dogs / Q000502:physiology*; D004347:Drug Interactions; D005260:Female; D006221:Halothane; D008614:Meperidine / Q000494:pharmacology*; D008733:Methoxyflurane; D009270:Naloxone / Q000494:pharmacology; D010111:Oxymorphone / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D010147:Pain Measurement / Q000662:veterinary; D011312:Pressure; D011674:Pulse / Q000187:drug effects; D012119:Respiration / Q000187:drug effects
D008733:Methoxyflurane; D009270:Naloxone; D000075:Acepromazine; D008614:Meperidine; D010111:Oxymorphone; D006221:Halothane